Floatz logo

Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta And Tyrosinase Related Protein 1

Unresectable Melanoma

Mayo Clinicgene_therapyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Unresectable Melanoma cohort.

Asset / SponsorPhaseRating
Lifileucel
Iovance Biotherapeutics, Inc.
Phase 3BB
Tocilizumab
University of Southern California
Phase 2B
Eb-Dtkn-401 Allogeneic Dual-Target Cspg4/Gd2 Car-Nk Cells
Beijing Biotech
Phase 1/2CCC
Iov-3001
Iovance Biotherapeutics, Inc.
Phase 1/2CCC
Navitoclax
National Cancer Institute (NCI)
Phase 1/2CC

View all 19 →

Same molecule, other indications

Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta And Tyrosinase Related Protein 1 is also rated in:

Metastatic Choroid MelanomaDormant
CC
Indicative ·
43 / 100
View asset →
Metastatic Mucosal MelanomaDormant
CC
Indicative ·
43 / 100
View asset →
Clinical Stage III Cutaneous Melanoma AJCC v8Dormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →